Immunic Historical Balance Sheet

IMUX -  USA Stock  

USD 8.67  0.28  3.34%

Trend analysis of Immunic balance sheet accounts such as Assets Non Current of 36.8 M or Cash and Equivalents of 137.5 M provides information on Immunic's total assets, liabilities, and equity, which is the actual value of Immunic to its prevalent stockholders. By breaking down trends over time using Immunic balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Immunic prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immunic is a good buy for the upcoming year.
Please see Risk vs Return Analysis.

Immunic Historical Statements 


About Immunic Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Immunic at a specified time, usually calculated after every quarter, six months, or one year. Immunic Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Immunic and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Immunic currently owns. An asset can also be divided into two categories, current and non-current.

Immunic Balance Sheet Chart

Immunic Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Immunic uses and utilizes its capital. It also shows what exactly a company owns and owes.
Immunic Total Assets are fairly stable at the moment as compared to the past year. Immunic reported Total Assets of 167.86 Million in 2020. Assets Non Current is likely to rise to about 36.8 M in 2021, whereas Accumulated Other Comprehensive Income is likely to drop (4.2 M) in 2021.

Total Assets

Total assets refers to the total amount of Immunic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immunic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; [TaxAssets] and [Receivables].

Current Assets

Current assets of Immunic include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Immunic. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Immunic balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Immunic books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; [DeferredRev]; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Immunic balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.Immunic Total Assets are fairly stable at the moment as compared to the past year. Immunic reported Total Assets of 167.86 Million in 2020. Assets Non Current is likely to rise to about 36.8 M in 2021, whereas Accumulated Other Comprehensive Income is likely to drop (4.2 M) in 2021.
 2018 2019 2020 2021 (projected)
Current Assets13.33 M32.23 M133.75 M105.89 M
Total Assets13.37 M65.95 M167.86 M181.11 M

Immunic balance sheet Correlations

Click cells to compare fundamentals

Immunic Account Relationship Matchups

Immunic balance sheet Accounts

201620172018201920202021 (projected)
Accumulated Other Comprehensive Income83 K78 K(819 K)(1.37 M)(4.11 M)(4.22 M)
Total Assets64.03 M60.38 M13.37 M65.95 M167.86 M181.11 M
Current Assets61.46 M58.12 M13.33 M32.23 M133.75 M105.89 M
Assets Non Current2.56 M2.26 M40 K33.73 M34.12 M36.81 M
Cash and Equivalents59.99 M56.9 M13.07 M29.37 M127.45 M137.51 M
Cash and Equivalents USD59.99 M56.9 M13.07 M29.37 M127.45 M137.51 M
Shareholders Equity58.45 M50.04 M(25.74 M)58.36 M158.78 M171.32 M
Shareholders Equity USD58.45 M50.04 M(25.74 M)58.36 M158.78 M171.32 M
Total Liabilities5.58 M10.34 M1.92 M7.59 M9.08 M12.78 M
Current Liabilities5.48 M10.28 M1.92 M7.07 M8.4 M8.23 M
Liabilities Non Current101 K100 K59 K520 K679 K696.87 K
Trade and Non Trade Payables780 K1.05 M1.4 M2.42 M3.7 M3.99 M
Property Plant and Equipment Net2.5 M2.15 M40 K713 K1.1 M1.38 M
Accumulated Retained Earnings Deficit(243.82 M)(295.95 M)(24.98 M)(59.91 M)(103.93 M)(112.13 M)

Immunic Investors Sentiment

The influence of Immunic's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunic. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - IMUX

Immunic Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Immunic. What is your judgment towards investing in Immunic? Are you bullish or bearish?
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunic using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunic information on this page should be used as a complementary analysis to other Immunic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Immunic Stock analysis

When running Immunic price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Directory
Find actively traded corporate debentures issued by US companies
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.